Cat /

Breed profile · FDA CVM July 2026 extract

Burmese adverse-event record

Adverse-event filings for Burmese (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.

#203 of 510
by report volume (all breeds)
158
FDA CVM reports on file
11.4%
death-coded share of reports
#39 of 275
by death-coded share (≥50 reports)

How the 158 reports break down

By recorded gender -- every report on file for Burmese, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 17 12.75 8.5 4.25 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Burmese drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Burmese ranks #203 of 510 by total reports (158) and #39 of 275 by death-coded share (11.4%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#203
This breed, reports of 510
#39
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Burmese has 158 reports now versus 156 in that prior snapshot: 2 more (1.3%).

Report change
+2
Death-coded reports
+1
Death-coded share
+0.5 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Burmese changes

Total Reports

158

Above-median volume

Deaths Reported

18

of 158 reports

Death-coded share of reports

11.4%

High death-coded share

Avg Age at Report

8.8 yr

4.2 kg avg weight

Death-Coded Outcome Share

Burmese death-coded reports 11.4%
Cross-breed median

11.4% of 158 burmese reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Burmese's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

11% 86th percentile Higher share than 86% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). Below this entry. 20%–25%: 2 indexed breeds (1%). Below this entry. 25%–30%: 3 indexed breeds (1%). Below this entry. 30%–35%: 4 indexed breeds (1%). Below this entry. 35%–40%: 5 indexed breeds (2%). Below this entry. 40%–45%: 6 indexed breeds (2%). Below this entry. 45%–50%: 3 indexed breeds (1%). Below this entry. 50%–55%: 7 indexed breeds (3%). Below this entry. 55%–60%: 7 indexed breeds (3%). Below this entry. 60%–65%: 21 indexed breeds (8%). Below this entry. 65%–70%: 11 indexed breeds (4%). Below this entry. 70%–75%: 15 indexed breeds (5%). Below this entry. 75%–80%: 13 indexed breeds (5%). Below this entry. 80%–85%: 11 indexed breeds (4%). Below this entry. 85%–90%: 12 indexed breeds (4%). Below this entry. 90%–95%: 12 indexed breeds (4%). Below this entry. 95%–100%: 142 indexed breeds (52%). This entry sits in this band. Burmese 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 4.2 kg (9.3 lbs)

Top Reported Reactions

Vomiting 19
Lethargy (see also Central nervous system depression in 'Neurological') 18
Anorexia 14
Ataxia 12
Death 10
Application site alopecia 9
Diarrhoea 9
Emesis 9

Most Referenced Drugs

Spinosad 19
Selamectin 18
Cefovecin 15
Frunevetmab 10
Buprenorphine 9
Selamectin;Sarolaner 9
Propofol 7
Imidacloprid + Moxidectin 7

Outcome Breakdown

Recovered/Normal
54 (37.8%)
Outcome Unknown
35 (24.5%)
Ongoing
34 (23.8%)
Died
11 (7.7%)
Euthanized
7 (4.9%)
Recovered with Sequela
2 (1.4%)

Gender Distribution

Male 91 (57.6%)
Female 63 (39.9%)
Unknown 4 (2.5%)

Reports by Year

Year Reports Trend
2010 11
2011 10
2012 14
2013 10
2014 12
2015 9
2016 11
2017 12
2018 5
2019 7
2020 7
2021 7
2022 6
2023 10
2024 17
2025 9
2026 1

Burmese: high death-coded share in the FDA CVM extract

Signature read: Burmese's 11.4% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Burmese sits at #203 of 510 by report volume among all breeds and #22 of 55 among cat breeds, with 158 reports and 18 (11.4%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #39 of 275. Mean age at report: 8.8 years, average weight 4.2 kg (9.3 lbs).

Top reported signs: Vomiting (19), Lethargy (see also Central nervous system depression in 'Neurological') (18), Anorexia (14). Most-referenced drug: Spinosad (19 reports), followed by Selamectin (18) and Cefovecin (15).

Outcome coding on 143 status-recorded reports is dominated by Recovered/Normal (37.8%). Annual submissions ranged 1-2,026 across 17 years on file.

Cat Breeds With a Similar Report Volume

Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Burmese, both outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (11.4% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (4.2 kg here).

What to do with this cat

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Burmese?
There are 158 adverse event reports involving Burmese in the FDA database, of which 18 were death-coded (11.4% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Burmese ranks #203 of 510 by report volume among all breeds PlainBreed indexes (#22 of 55 among cat breeds).
Where does Burmese sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Burmese is #203 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Cat, it is #22 of 55. Among breeds with at least 50 reports, its death-coded share ranks #39 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Burmese?
The most commonly reported adverse reactions for Burmese are Vomiting (19 reports), Lethargy (see also Central nervous system depression in 'Neurological') (18 reports), Anorexia (14 reports), Ataxia (12 reports), Death (10 reports).
What drugs are most frequently associated with Burmese adverse events?
The drugs most frequently referenced in Burmese adverse event reports are Spinosad (19 reports), Selamectin (18 reports), Cefovecin (15 reports), Frunevetmab (10 reports), Buprenorphine (9 reports).
What is the average age of Burmese in adverse event reports?
The average age of Burmese at the time of adverse event reports is 8.8 years, with an average weight of 4.2 kg (9.3 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Burmese (Cat), extract as of July 2026 extract. 158 reports · 18 death-coded (11.4% of reports, not a mortality rate) · #203 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →